Itraconazole-Induced Increases in Gilteritinib Exposure Are Mediated by CYP3A and OATP1B is a research paper published in Molecules (2022). On theSindex it has a DataRank of 0. It has been cited 10 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01CA138744
National Institutes of Health
Grant: U24CA247648
National Institutes of Health
Grant: R01CA215802
National Institutes of Health
Grant: F31CA254151
National Institutes of Health
Grant: P30 CA02176
OSU Comprehensive Cancer Center Pelotonia Foundation
Grant: to A.S., S.H., and S.D.B.
Pelotonia Fellowship Program
Grant: E.D.E.
Eli Lilly Fellowship Program
Grant: D.A.G.
National Institutes of Health
Grant: 5U24CA247648-04
The Chesapeake-Ohio Pharmacokinetics Core for The ETCTN
National Institutes of Health
Grant: 5R01CA138744-07
Tyrosine kinase inhibitors for the treatment of childhood AML
National Institutes of Health
Grant: 5R01CA215802-04
(9) Therapeutic strategies to mitigate toxicities of platinum-based therapeutics
National Institutes of Health
Grant: 1F31CA254151-01
Intentional Modulation of Ibrutinib Pharmacokinetics through CYP3A Inhibition
FWCI
1.33
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals